Key Insights for Understanding Stock Investments

Shares of Industrials sector company Agilent Technologies moved 0.1% today, and are now trading at a price of $131.49. The Large-Cap stock's daily volume was 52,126 compared to its average volume of 1,553,658. The S&P 500 index returned a 0.0% performance.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company is based in Santa Clara and has 18,000 full time employees. Its market capitalization is $38,340,907,008. Agilent Technologies currently offers its equity investors a dividend that yields 0.7% per year.

16 analysts are following Agilent Technologies and have set target prices ranging from $125.0 to $153.0 per share. On average, they have given the company a rating of buy. At today's prices, A is trading -5.61% away from its average analyst target price of $139.31 per share.

Over the last year, A's share price has increased by 11.2%, which represents a difference of -11.1% when compared to the S&P 500. The stock's 52 week high is $155.35 per share whereas its 52 week low is $96.8. With average free cash flows of $1.06 Billion that have been growing at an average rate of 10.7% over the last 5 years, Agilent Technologies is in a position to continue its strong stock performance trend.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023 1,772,000 298,000 1,474,000 44.37
2022 1,312,000 291,000 1,021,000 -21.28
2021 1,485,000 188,000 1,297,000 61.72
2020 921,000 119,000 802,000 -7.39
2019 1,021,000 155,000 866,000 -4.84
2018 1,087,000 177,000 910,000
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.